This story originally ran on June 10.

Proteomic diagnostic developer Correlogic this week announced that it had obtained CE marking from the European Union for its OvaCheck protein biomarker blood test for the detection of epithelial ovarian cancer.

The certification allows the company to offer OvaCheck commercially in Europe as it continues to seek FDA approval for the test in the US.

Sales of the test in Europe are still several months away, Correlogic CEO Peter Levine told ProteoMonitor.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.